News | Nuclear Imaging | January 05, 2017

Societies Call for Focus on Radiation Dose Optimization in Nuclear Cardiology

Nuclear cardiology, dose reduction, myocardial perfusion imaging

January 5, 2017 — Working in concert, the American Society of Nuclear Cardiology (ASNC), the Intersocietal Accreditation Commission (IAC)’s Nuclear/PET accreditation division and the Society of Nuclear Medicine in Molecular Imaging (SNMMI) are mandating optimized radiation doses in conjunction with the nuclear cardiology studies (i.e., myocardial perfusion imaging) performed throughout the United States and beyond.

These efforts come in response to recently published research[1,2] demonstrating that adherence to clinical nuclear imaging guidelines for reduced patient radiation exposure is variably implemented, resulting in administration of higher doses than necessary for some patients undergoing myocardial perfusion studies. 

In February 2016, ASNC published guidelines for myocardial perfusion SPECT imaging, ASNC Imaging Guidelines for SPECT Nuclear Cardiology Procedures: Stress Protocols and Tracers, which include a chart entitled “Current SPECT Myocardial Perfusion Imaging Protocols: Recommended Radiopharmaceutical Activities and Their Corresponding Radiation Effective Doses.” These recommendations provide guidance for practitioners and are based on ASNC’s guiding principle of performing the most appropriate study that provides the highest quality data to aid in medical decision-making and minimizes risks to patients. Dose reduction strategies based on weight-based radiotracer dosing, thoughtful selection of radiotracer, stress-only imaging when appropriate, software innovations, state-of-the-art SPECT systems and utilization of PET for myocardial perfusion imaging are all methods supported by ASNC to achieve quality cardiac imaging at the lowest radiation exposure.

“ASNC is committed to supporting nuclear cardiac imaging labs’ use of the lowest radiotracer dose that maintains diagnostic image quality, in conjunction with application of appropriate use criteria (AUC) and the use of count recovery software for general SPECT cameras, new solid state SPECT cameras, and PET to provide the right test for the right patient,” said Brian G. Abbott, M.D., FACC, MASNC, ASNC president.

To ensure that facilities seeking nuclear cardiology accreditation focus their awareness on the patient dose they are administering, the September 2016 published revision to the IAC Standards and Guidelines for Nuclear/PET Accreditation is inclusive of required administered dose ranges as recommended by the 2016 ASNC guidelines. In accordance with the IAC’s mission of improving healthcare through accreditation®, the IAC Nuclear/PET Board of Directors has made the decision to mandate specific dose ranges for myocardial perfusion imaging studies to decrease radiation exposure while maintaining image quality, thus ensuring patient safety. 

“Our ultimate goal is to ensure that nuclear cardiology facilities are guided to administer the lowest dose possible that provides optimal imaging results for patients referred for myocardial perfusion imaging studies,” said Scott D. Jerome, DO, FACC, FASNC, FSCCT, IAC Nuclear/PET president

Speaking on behalf of the SNMMI, President Sally W. Schwarz, MS, RPh, BCNP, stated, “Working together, we can more effectively ensure that health care providers meet accreditation requirements and follow dose guidelines for nuclear cardiology. The goal is to keep radiation exposure as low as is reasonable.” 

Frederic H. Fahey, DSc, FSNMMI, who serves on SNMMI’s Dose Optimization Task Force, added, “Accreditation requirements and dosing guidelines emphasize both patient safety and quality images. Our focus must always be on providing the highest quality care in the safest manner possible.”

ASNC is a leader in quality, education, advocacy and standards in cardiovascular imaging, with nearly 4,000 members worldwide. For more information, visit www.asnc.org.

IAC is a nonprofit organization offering accreditation programs for vascular testing, echocardiography, nuclear/PET, MRI, diagnostic CT, dental CT, carotid stenting, vein treatment and management and cardiac electrophysiology. For more information: intersocietal.org

SNMMI is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging. SNMMI’s more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging. For more information: snmmi.org.

References:
1. Jerome SD, Tilkemeier PL, Farrell, MB, Shaw LJ. “Nationwide Laboratory Adherence to Myocardial Perfusion Imaging Radiation Dose Reduction Practices: A Report From the Intersocietal Accreditation Commission Data Repository.” J Am Coll Cardiol Img. 2015;8(10):1170-1176. doi:10.1016/j.jcmg.2015.07.008 

2. Mathew Mercuri; Thomas N. B. Pascual; John J. Mahmarian; Leslee J. Shaw; et al. for the INCAPS Investigators Group. “Comparison of Radiation Doses and Best-Practice Use for Myocardial Perfusion Imaging in US and Non-US Laboratories/ Findings From the IAEA (International Atomic Energy Agency) Nuclear Cardiology Protocols Study.” JAMA Intern Med. 2016;176(2):266-269. doi:10.1001/jamainternmed.2015.7102.) 

 

Read the article "Recent Advances in Cardiac Nuclear Imaging Technology." 

Watch the VIDEO "PET vs. SPECT in Nuclear Cardiology and Recent Advances in Technology." An interview with Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and president-elect of the American Society of Nuclear Cardiology (ASNC), explained advances in PET and SPECT imaging. 

Watch the VIDEO "Trends in Nuclear Cardiology Imaging." A discussion with David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American Society of Nuclear Cardiology (ASNC), discusses advancements in nuclear imaging and some of the issues facing the subspecialty. 

Related Content

Rafael Rivero, M.D., Global Head of Medical Affairs at MSI, said: "The importance of MyoStrain cannot be understated because of the test's immense clinical value and ability to quantify intramyocardial dysfunction across 48 segments of the heart. In a six-heartbeat MRI scan, MyoStrain arms physicians with novel clinical information about a patient's heart health."
News | Cardiac Imaging | August 11, 2020
August 11, 2020 — Myocardial Solutions, Inc. and United Imaging, Inc.
The Mindways Solid phantom with volume of interest in the quality assurance phantom (red circles, left side). A participant's noncontrast-enhanced axial CT (right side) with volume of interest (yellow circles) in the trabecular bone compartment of three vertebrae for bone mineral density measurements. Image courtesy of Radiological Society of North America

The Mindways Solid phantom with volume of interest in the quality assurance phantom (red circles, left side). A participant's noncontrast-enhanced axial CT (right side) with volume of interest (yellow circles) in the trabecular bone compartment of three vertebrae for bone mineral density measurements. Image courtesy of Radiological Society of North America

News | Cardiac Imaging | July 15, 2020
July 15, 2020 — ...
Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

News | Cardiac Imaging | June 29, 2020
June 29, 2020 — A type of smart magnetic r...
New Multimodality Cardiac Imaging Guidelines for Competitive Athletes Created. ASE SCCT and SCMR recommendations for imaging, screening atheletes.
News | Cardiac Imaging | May 11, 2020
May 11, 2020 – Competitive athletes are a rapidly growing population worldwide.
Figure 4 for the study. Images of a 65-year-old man (patient 6). (a) Cardiac MRI perfusion shows perfusion deficit of anterior/anterolateral wall attributed to left anterior descending artery/left circumflex artery (*). (b) CT coronary angiography. (c) Coronary angiography, left anterior oblique projection with caudal angulation. (d) Three-dimensional image fusion helped refine diagnosis: perfusion deficits (*) were most likely caused by narrow first diagonal branch and its first, stented side branch (arrow

Figure 4 for the study. Images of a 65-year-old man (patient 6). (a) Cardiac MRI perfusion shows perfusion deficit of anterior/anterolateral wall attributed to left anterior descending artery/left circumflex artery (*). (b) CT coronary angiography. (c) Coronary angiography, left anterior oblique projection with caudal angulation. (d) Three-dimensional image fusion helped refine diagnosis: perfusion deficits (*) were most likely caused by narrow first diagonal branch and its first, stented side branch (arrowhead). Retrospectively, denoted lesion could also be found at CT coronary angiography and coronary angiography (arrowheads in b and c, respectively). CT FFR = CT-derived fractional flow reserve, LGE = late gadolinium enhancement. Image courtesy of RSNA, Radiology.

News | Cardiac Imaging | May 04, 2020
May 4, 2020 – A new technique that combines computed tomography (CT) and magnetic resonance imaging MRI can bolster c
An example of a coronary computed tomography angiography (CCTA) exam. The CIAO study looked at patients who have a problem of blood flow limitation and chest pain symptoms in the absence of a 50 percent or more artery narrowing, known as ischemia with no obstructive CAD, or INOCA.

An example of a coronary computed tomography angiography (CCTA) exam. The CIAO study looked at patients who have a problem of blood flow limitation and chest pain symptoms in the absence of a 50 percent or more artery narrowing, known as ischemia with no obstructive CAD, or INOCA.

News | Cardiac Imaging | April 03, 2020
April 3, 2020 — Patients who experience chest pain and have abnormal results on a cardiac stress test but who do not
Schematic depiction of the automated process for assessing fat, muscle, liver, aortic calcification, and bone from original abdominal CT scan data

Figure 1: Depiction of the fully automated CT biomarkers tools used in this study. (A) Schematic depiction of the automated process for assessing fat, muscle, liver, aortic calcification, and bone from original abdominal CT scan data. (B) Case example in an asymptomatic 52-year-old man undergoing CT for colorectal cancer screening. At the time of CT screening, he had a body-mass index of 27·3 and Framingham risk score of 5% (low risk). However, several CT-based metabolic markers were indicative of underlying disease. Multivariate Cox model prediction based on these three CT-based results put the risk of cardiovascular event at 19% within 2 years, at 40% within 5 years, and at 67% within 10 years, and the risk of death at 4% within 2 years, 11% within 5 years, and 27% within 10 years. At longitudinal clinical follow-up, the patient suffered an acute myocardial infarction 3 years after this initial CT and died 12 years after CT at the age of 64 years. (C) Contrast-enhanced CT performed 7 months before death for minor trauma was interpreted as negative but does show significant progression of vascular calcification, visceral fat, and hepatic steatosis. HU=Hounsfield units.

News | Cardiac Imaging | March 06, 2020
March 6, 2020 — Researchers at the National Institutes of Health a